Patients who received optimal treatment with mitomycin C or BCG had similar recurrence-free and progression-free survival at 4 years.

The hormone sensitivity of breast tissue makes it even more susceptible to damage from ionizing radiation from imaging ...

Results of the AGAVE-201 trial demonstrate a high incidence of response to axatilimab among patients with chronic graft-versus-host disease.

Researchers sought to determine factors related to complete response in managing LARC with total neoadjuvant therapy.

Researchers sought to determine whether high antimetabolite dose intensity is related to higher treatment-induced toxicity in pediatric patients with ALL.

Under most pessimistic scenario, one dose would avert fewer cervical cancer cases with difference of 3 percent over 100 years.

A mouse xenograft model of DLBCL tumors was used to characterize the role of TNFAIP3 expression tumor growth. Tumors induced from cells with higher levels of TNFAIP3 had a lower volume compared with ...

Feasibility study highlights an unmet need of patients receiving palliative radiotherapy for bone metastases pain, but the intervention was not as feasible for staff.

Researchers aimed to identify a standardized practice for the early detection of cutaneous melanoma recurrence.

A meta-analysis of studies showed netupitant-palonosetron more effectively prevented CINV, particularly in the overall and delayed phases, compared with aprepitant.

The MammaPrint assay may be able to identify patients with HR+ early breast cancer who could benefit from extended letrozole therapy beyond 5 years, according to researchers.

Omitting the 5-fluorouracil bolus from multidrug regimens could improve the tolerability of treatment without compromising efficacy in patients with advanced gastrointestinal cancers, a new study ...